Glycosaminoglycans

serpin family D member 1 ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 21805439 Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis. 2011 Jun 1
2 20670608 Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli. 2010 Nov 15 4
3 17222891 Effect of oversulfated dermatan sulfate derivatives on platelet aggregation. 2007 1
4 15078125 Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfate. 2004 5
5 15196911 RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins. 2004 Jun 18 1
6 15292227 Molecular mapping of the thrombin-heparin cofactor II complex. 2004 Oct 8 3
7 11856753 Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition. 2002 May 31 3
8 12169660 Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. 2002 Aug 20 1
9 12413592 Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II. 2002 Jul 15 4
10 11323006 Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. 2001 Mar 15 2
11 11776053 Basic and clinical study on the antithrombotic mechanism of glycosaminoglycan extracted from sea cucumber. 2000 Aug 1
12 10574918 Enhancement of heparin cofactor II anticoagulant activity. 1999 Dec 3 2
13 9112638 Prevalence of heparin cofactor II deficiency in patients with a history of venous thrombosis. 1996 Jan-Feb 2
14 7806495 Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans. 1994 Dec 30 2
15 8429040 Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity. 1993 Feb 15 1
16 1381850 Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins. 1992 Jun 1 1
17 1646210 Immobilization of dermatan sulphate on a silica matrix and its possible use as an affinity chromatography support for heparin cofactor II purification. 1991 Feb 22 2
18 1939083 The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans. 1991 Oct 25 1
19 2266131 Glycosaminoglycan-mediated leuserpin-2/thrombin interaction. Structure-function relationships. 1990 Dec 25 1
20 2318889 On the activation of human leuserpin-2, a thrombin inhibitor, by glycosaminoglycans. 1990 Mar 25 6
21 2713501 Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity. 1989 May 1 1
22 3603428 Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation. 1987 Apr 15 1
23 3755134 Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II. 1986 Jul 5 1
24 6084876 Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. 1984 Dec 15 3
25 6687888 Activation of heparin cofactor II by dermatan sulfate. 1983 Jun 10 2